Percentages of participants discontinuing assigned treatment for reasons other than microbiologic ineligibility were similar across groups ( rifampin , 8.2 % ; rifapentine 10 , 15 , or 20 mg/kg , 3.4 , 2.5 , and 7.4 % , respectively ) .